Antiviral and anti-inflammatory therapies in COVID-19

被引：11

作者：

Szekanecz Zoltan ^{[1
]}

Bogos Krisztina ^{[2
]}

Constantin Tamas ^{[3
]}

Fullesdi Bela ^{[4
]}

Muller Veronika ^{[5
]}

Rakoczi Eva ^{[1
]}

Varkonyi Istvan ^{[6
]}

Valyi-Nagy Istvan ^{[7
]}

机构：

[1] Debreceni Egyet, Altalanos Orvostud Kar, Belgyogyaszati Klin, Reumatol, Debrecen, Hungary

[2] Orszagos Koranyi Pulmonol Int, Budapest, Hungary

[3] Semmelweis Egyet, Altalanos Orvostud Kar, Gyermekgyogyaszati Klin 2, Budapest, Hungary

[4] Debreceni Egyet, Altalanos Orvostud Kar, Aneszteziol & Intenz Terapias Klin, Debrecen, Hungary

[5] Semmelweis Egyet, Altalanos Orvostud Kar, Pulmonol Klin, Budapest, Hungary

[6] Debreceni Egyet, Altalanos Orvostud Kar, Infektol Klin, Debrecen, Hungary

[7] Del Pesti Ctr Korhaz, Orszagos Hematol & Infektol Int, Budapest, Hungary

来源：

ORVOSI HETILAP | 2021年 / 162卷 / 17期

关键词：

novel coronavirus infection (COVID-19); coronavirus; cytokine storm; antiviral treatment; cytokine in-hibition treatment; corticosteroid; interleukin-6; inhibition; Janus kinase inhibition; intravenous immunoglobulin; TOCILIZUMAB; MULTICENTER;

D O I：

10.1556/650.2021.32230

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The novel coronavirus infection (COVID-19) places a heavy burden on the health care system and our society. There are three major stages in the disease that fundamentally determine treatment approaches. Phases I?IIA require primarily antiviral treatment. In phases IIB?III, anti-inflammatory treatment is needed accompanied by intensive and supportive care. This recommendation applies only to pharmacotherapy and summarizes the therapeutic options based on the available evidence. It also includes a proposed treatment algorithm.

引用

页码：643 / 651

页数：9

共 50 条

[41] Perioperative Nonsteroidal Anti-Inflammatory Agents in the COVID-19 Orthopedic Patient
Wu, Christopher L.
Jules-Elysee, Kethy M.
Kirksey, Meghan A.
Liguori, Gregory A.
HSS JOURNAL, 2020, 16 (1_SUPPL) : 97 - 101
[42] A Case of COVID-19 with Acute Exacerbation after Anti-Inflammatory Treatment
Ashino, Yugo
Shirato, Yoichi
Yaegashiwa, Masahiro
Yamanouchi, Satoshi
Miyakawa, Noriko
Ando, Kokichi
Sakurada, Yumiko
Yasutan, Haorile Chagan
Hattori, Toshio
REPORTS, 2022, 5 (02)
[43] Non-steroidal anti-inflammatory drugs, prostaglandins, and COVID-19
Robb, Calum T.
Goepp, Marie
Rossi, Adriano G.
Yao, Chengcan
BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (21) : 4899 - 4920
[44] Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'
Perricone, Carlo
Bartoloni, Elena
Cafaro, Giacomo
Caporali, Roberto
Gerli, Roberto
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (04)
[45] Non-steroidal anti-inflammatory drug use in COVID-19
不详
LANCET RHEUMATOLOGY, 2021, 3 (07): : E465 - E465
[46] The use of nonsteroidal anti-inflammatory drugs by COVID-19 patients - in a nutshell
Flepisi, B. T.
Schellack, N.
SA PHARMACEUTICAL JOURNAL, 2021, 88 (03) : 35 - 38
[47] Anti-inflammatory aspects of Lidocaine: a neglected therapeutic stance for COVID-19
Maab, Hira
Mustafa, Faryal
Ali, Shajeea Arshad
HEART & LUNG, 2020, 49 (06): : 877 - 878
[48] Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?
Nasiripour, Somayyeh
Zamani, Farhad
Farasatinasab, Maryam
JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (07): : 828 - 829
[49] Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy
Pisoschi, Aurelia Magdalena
Pop, Aneta
Iordache, Florin
Stanca, Loredana
Geicu, Ovidiu Ionut
Bilteanu, Liviu
Serban, Andreea Iren
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 232
[50] Antiviral and Anti-Inflammatory Treatment with Multifunctional Alveolar Macrophage-Like Nanoparticles in a Surrogate Mouse Model of COVID-19
Li, Bin
Wang, Wei
Song, Weifeng
Zhao, Zheng
Tan, Qingqin
Zhao, Zhaoyan
Tang, Lantian
Zhu, Tianchuan
Yin, Jialing
Bai, Jun
Dong, Xin
Tan, Siyi
Hu, Qunying
Tang, Ben Zhong
Huang, Xi
ADVANCED SCIENCE, 2021, 8 (13)

← 1 2 3 4 5 →